GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $12,000 | +20.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $10,000 | -16.7% | 100 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $12,000 | +20.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $10,000 | -16.7% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $12,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $12,000 | -33.3% | 100 | 0.0% | 0.00% | -40.0% |
| Q2 2019 | $18,000 | 0.0% | 100 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $18,000 | +80.0% | 100 | 0.0% | 0.01% | +66.7% |
| Q4 2018 | $10,000 | -44.4% | 100 | 0.0% | 0.00% | -40.0% |
| Q3 2018 | $18,000 | +28.6% | 100 | 0.0% | 0.01% | +25.0% |
| Q2 2018 | $14,000 | -99.9% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $11,268,000 | -14.6% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $13,202,000 | +1199.4% | 100 | +900.0% | 0.00% | – |
| Q3 2017 | $1,016,000 | -88.1% | 10 | -88.2% | 0.00% | -100.0% |
| Q2 2017 | $8,521,000 | -17.1% | 85 | -1.2% | 0.00% | -33.3% |
| Q1 2017 | $10,280,000 | +8.2% | 86 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $9,500,000 | +107.4% | 86 | +72.0% | 0.00% | +200.0% |
| Q2 2016 | $4,580,000 | +26.9% | 50 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $3,608,000 | +3.9% | 50 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $3,472,000 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|